Rockefeller Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.6K Hold
3,454
﹤0.01% 3415
2026
Q1
$32.5K Buy
3,454
+2,161
+167% +$19.4K ﹤0.01% 3482
2025
Q4
$10.5K Buy
1,293
+693
+116% +$7.57K ﹤0.01% 3786
2025
Q3
$8.52K Buy
+600
New +$7.92K ﹤0.01% 3715
2023
Q1
Sell
-1,107
Closed -$29K 2269
2022
Q4
$29K Sell
1,107
-200
-15% -$6.53K ﹤0.01% 2642
2022
Q3
$37K Sell
1,307
-109
-8% -$2.8K ﹤0.01% 2499
2022
Q2
$29K Buy
1,416
+116
+9% +$2.17K ﹤0.01% 2528
2022
Q1
$28K Hold
1,300
﹤0.01% 2578
2021
Q4
$36K Buy
1,300
+200
+18% +$4.85K ﹤0.01% 2350
2021
Q3
$23K Sell
1,100
-15,000
-93% -$281K ﹤0.01% 2518
2021
Q2
$265K Hold
16,100
﹤0.01% 1405
2021
Q1
$201K Sell
16,100
-15,100
-48% -$160K ﹤0.01% 1329
2020
Q4
$276K Buy
+31,200
New +$254K ﹤0.01% 1090

Other funds holding CCRN

Rockefeller Capital Management's CCRN Position: Q2 2026 in Review

Rockefeller Capital Management held its Cross Country Healthcare (CCRN) position steady in Q2 2026 at 3,454 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.

Rockefeller Capital Management first reported a position in CCRN in Q4 2020 and has held it in 13 quarters since. The position peaked at $276K in Q4 2020. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Rockefeller Capital Management held 3,454 shares of Cross Country Healthcare worth $45.6K as of Q2 2026.
  • Rockefeller Capital Management left its Cross Country Healthcare share count unchanged in Q2 2026.
  • Cross Country Healthcare made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3415 holding.
  • Rockefeller Capital Management first reported a position in Cross Country Healthcare in Q4 2020 and has held it in 13 quarters since.
  • Rockefeller Capital Management's Cross Country Healthcare position peaked at $276K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.